Evidence map›Paper›PMID 30382303›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

Fabrizio De Carli, Flavio Nobili, Marco Pagani, Matteo Bauckneht, Federico Massa, Matteo Grazzini, Cathrine Jonsson, Enrico Peira, Silvia Morbelli, Dario Arnaldi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Digital biomarker-based individualized prognosis for people at risk of dementia.Alzheimer's & dementia (Amsterdam, Netherlands) · 2020
    Article
  6. Article
  7. Article
  8. Combined 18F-FDG PET-CT markers in dementia with Lewy bodies.Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fabrizio De CarliInstitute of Molecular Bioimaging and Physiology, National Research Council, Largo Paolo Daneo, 3, 16132, Genoa, Italy. f.decarli@ibfm.cnr.it.ORCID 0000-0002-1841-5146
Flavio NobiliDepartment of Neuroscience (DINOGMI), IRCCS Polyclinic San Martino-IST, University of Genoa, Genoa, Italy.
Marco PaganiInstitute of Cognitive Sciences and Technologies, CNR, Rome, Italy.
Matteo BaucknehtDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Federico MassaDepartment of Neuroscience (DINOGMI), IRCCS Polyclinic San Martino-IST, University of Genoa, Genoa, Italy.
Matteo GrazziniDepartment of Neuroscience (DINOGMI), IRCCS Polyclinic San Martino-IST, University of Genoa, Genoa, Italy.
Cathrine JonssonMedical Radiation Physics and Nuclear Medicine, Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
Enrico PeiraNational Institute of Nuclear Physics (INFN), Genoa, Italy.
Silvia MorbelliDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Dario ArnaldiDepartment of Neuroscience (DINOGMI), IRCCS Polyclinic San Martino-IST, University of Genoa, Genoa, Italy.
Alzheimer’s Disease Neuroimaging Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to verify the reliability and generalizability of an automatic tool for the detection of Alzheimer-related hypometabolic pattern based on a Support-Vector-Machine (SVM) model analyzing

methodsThe SVM model processed metabolic data from anatomical volumes of interest also considering interhemispheric asymmetries. It was trained on a homogeneous dataset from a memory clinic center and tested on an independent multicentric dataset drawn from the Alzheimer's Disease Neuroimaging Initiative. Subjects were included in the study and classified based on a diagnosis confirmed after an adequate follow-up time.

resultsThe accuracy of the discrimination between patients with Alzheimer Disease (AD), in either prodromal or dementia stage, and normal aging subjects was 95.8%, after cross-validation, in the training set. The accuracy of the same model in the testing set was 86.5%. The role of the two datasets was then reversed, and the accuracy was 89.8% in the multicentric training set and 88.0% in the monocentric testing set. The classification rate was also evaluated in different subgroups, including non-converter mild cognitive impairment (MCI) patients, subjects with MCI reverted to normal conditions and subjects with non-confirmed memory concern. The percent of pattern detections increased from 77% in early prodromal AD to 91% in AD dementia, while it was about 10% for healthy controls and non-AD patients.

conclusionsThe present findings show a good level of reproducibility and generalizability of a model for detecting the hypometabolic pattern in AD and confirm the accuracy of FDG-PET in Alzheimer disease.

Indexed as

Image Processing, Computer-AssistedPositron-Emission TomographyAgedAlzheimer DiseaseAutomationBrainFemaleFluorodeoxyglucose F18HumansMaleSupport Vector MachineFluorodeoxyglucose F18Alzheimer diseaseClassification and predictionDiscriminant analysisFDG-PETMCI due to ADNeurodegenerative disordersNeuroimage classificationSupport vector machine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.